<p>The integration of artificial intelligence (AI) and cognitive behaviour therapy (CBT) is a revolutionary solution to the global mental health issue, characterized by increasing need and decreased access to treatment. This research investigates the potential of AI-fortified cognitive behavioural therapy technologies, including chatbots, virtual reality, and adaptive learning modules, to enhance the efficacy, accessibility, and individualization of treatment for anxiety, depression, and PTSD. The study evaluates the scalability, ethical issues, and therapeutic efficacy of the therapies by combining peer-reviewed and experimental data. The suggested methodology combines AI-driven conversational therapy with predictive modelling to deliver individualized, real-time mental health treatment. In this study, a conceptual chatbot prototype, designated BECK-AI BOT, was developed to illustrate the application’s interface and functionality, enhancing accessibility for both patients and therapists in the future. This study does not present new clinical trial data. All reported symptom-reduction and engagement findings are drawn from previously published studies of existing AI-driven CBT systems (e.g., Woebot, Wysa, Eleos, Limbic). The present work offers a narrative synthesis of current evidence and introduces a conceptual architecture and prototype (BECK-AI BOT), without evaluating it clinically. Notwithstanding these difficulties, problems persist, including a lack of long-term efficacy statistics, cultural sensitivity issues, and moral reservations about over-reliance on AI during emergencies. The argument comes in the form of AI possibly improving, not replacing, human therapists, emphasizing hybrid systems for fair treatment. Future research needs to advance emotional intelligence within AI, which combines AI-driven conversational therapy and predictive modelling to deliver real-time, personalized mental health services.</p>